Review
[Concomitant chemoradiotherapy in nasopharyngeal carcinoma]
[Article in
Czech]
Affiliations
- PMID: 12924044
Item in Clipboard
Review
[Concomitant chemoradiotherapy in nasopharyngeal carcinoma]
[Article in
Czech]
Cas Lek Cesk.
2003.
Abstract
Radiotherapy is a standard treatment method for the nasopharyngeal carcinoma due to the anatomy of these tumors and their easy locoregional spreading. Surgery is used only in case of recurrent or persistent lymph node involvement. Nasopharyngeal carcinomas are dose dependent. Results of conventional and fractionation radiotherapy has reached a stable level. Improvement of local control and overall survival depends on new technologies and research results. Concomitant chemoradiotherapy represents a standard method in the treatment of locally progressive disease. Hyperfractionated or accelerated radiotherapy combined with chemotherapy has been used in some clinical studies to shorten the treatment time.
Similar articles
-
[Efficacy of primary and combined radiotherapy in locally advanced cancer of oropharynx and nasopharynx in III and IV stage].Otolaryngol Pol. 2005;59(2):229-34. Otolaryngol Pol. 2005. PMID: 16095093 Polish.
-
Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.Head Neck. 2004 May;26(5):389-95. doi: 10.1002/hed.10398. Head Neck. 2004. PMID: 15122654 Clinical Trial.
-
Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. An analysis of 43 consecutive patients.Strahlenther Onkol. 2004 Jul;180(7):425-33. doi: 10.1007/s00066-004-1202-9. Strahlenther Onkol. 2004. PMID: 15241530
-
[Carcinoma of the nasopharynx. Radiotherapy modalities and combined radiotherapy and chemotherapy: state of the art and perspectives].Cancer Radiother. 2001 Nov;5 Suppl 1:195s-200s. Cancer Radiother. 2001. PMID: 11797282 Review. French.
-
[Present status of treatment in nasopharyngeal carcinoma?].Strahlenther Onkol. 2003 May;179(5):283-91. doi: 10.1007/s00066-003-1086-0. Strahlenther Onkol. 2003. PMID: 12740654 Review. German.